ℹ️
🇬🇧
Search
Search for people relevant for "kinase inhibitors"
kinase inhibitors
Person
Class
Person
Publication
Programmes
Export current view
doc. PharmDr. Martina Čečková Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
1 study programme
5 classes
69 publications
Study programme
programme
Pharmaceutical Sciences
🇬🇧 NMgr. |
Faculty of Pharmacy in Hradec Králové
Classes
class
Pharmacokinetics
+2
GAF323 |
Faculty of Pharmacy in Hradec Králové
class
Diploma Thesis
GAPS206 |
Faculty of Pharmacy in Hradec Králové
class
Current strategies in pharmacotherapy
GF360 |
Faculty of Pharmacy in Hradec Králové
Publications
publication
Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy
2022 |
Faculty of Pharmacy in Hradec Králové
publication
ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors
2020 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
In vitro function and in situ localization of Multidrug Resistance-associated Protein (MRP)1 (ABCC1) suggest a protective role against methyl mercury-induced oxidative stress in the human placenta
2020 |
Faculty of Pharmacy in Hradec Králové
Load more publications (59)
Loading network view...